[Treatment of prostatic carcinoma in an advanced stage. Our experience].
The authors report the results of a retrospective study regarding 214 patients (mean age 73, smallest follow-up 6 months, greatest 70 months, average 42 months) affected by advanced prostatic cancer histologically demonstrated, observed from January 1983 to December 1990 and subject to hormonal treatment. They particular compared so-called "total androgenic suppression" (Gn-RH analogous or orchiectomy plus antiandrogen) with the "partial androgenic suppression" (Gn-RH analogous or orchiectomy). The authors report the results of the treatment regarding the subjective and the objective response, evaluated with NPCP criteria. Moreover the actuarial aspects of response and survival curves of two groups of patients are compared. The authors conclude that total compared to partial androgenic suppression does not offer significant advantages as regards to objective response and present their current treatment of advanced prostatic cancer.
Dublino
M
M
Divisione Urologica, Ospedale G. Bosco, Torino.
Lasaponara
F
F
Rizzello
N
N
D000206:Actuarial Analysis; D000368:Aged; D000369:Aged, 80 and over; D003131:Combined Modality Therapy; D017373:Cyproterone Acetate / Q000627:therapeutic use*; D004054:Diethylstilbestrol / Q000627:therapeutic use*; D005485:Flutamide / Q000627:therapeutic use*; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome
D017273:Goserelin; D017373:Cyproterone Acetate; D004054:Diethylstilbestrol; D005485:Flutamide
Il trattamento del carcinoma prostatico in stadio avanzato. Nostra esperienza.